Alzex Neuropharma Inc.

OTCPK:TRRI Stock Report

Market Cap: US$433.5k

Alzex Neuropharma Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Robert Rosner

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

No updates


CEO

Robert Rosner (59 yo)

no data

Tenure

Mr. Robert Rosner serves as Chief Financial Officer and Director of Fairchild Gold Corp. since June 09, 2022. Mr. Rosner is Chief Executive Officer and President of 27 Red Capital Inc. He serves as Preside...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.